References
- prb.org [Internet]. Washington, DC: Population Reference Bureau; [Cited 2011 Apr 27]. Available from: www.prb.org/
- Khattak MF, Saleem M. Prevalence of heterozygous beta-thalassemia in northern areas of Pakistan. J Pak Med Assoc. 1992;42:32–4.
- Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341:99–109.
- Baig SM. Molecular diagnosis of beta-thalassemia by multiplex ARMS-PCR: a cost effective method for developing countries like Pakistan. Prenat Diagn. 2007;27:580–1.
- Baig SM, Azhar A, Hassan H, Baig JM, Kiyani A, Hameed U, et al.. Spectrum of beta-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. Haematologica. 2006;91:ELT02.
- Lodhi Y. Economics of thalassemia management in Pakistan. In: , Ahmed S, ed, editor. Thalassemia awareness week. Friends of Thalassemia; 2003.
- Ghani R, Manji MA, Ahmed N. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Southeast Asian J Trop Med Public Health. 2002;33:855–61.
- Rahman M, Lodhi Y. Prospects and future of conservative management of beta thalassemia major in a developing country. Pak J Med Sci. 2004;20:105–12.
- Riaz H, Riaz T, Ullah F, Aziz S, Khan MU, Pervaiz R, et al.. Assessment of the seroprevalence of viral hepatitis B, viral hepatitis C and HIV in multitransfused thalassaemia major patients in Karachi, Pakistan. Trop Doct. 2010;41:23–5.
- Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13:9–19.
- Bouhass RA, Kabouya EA, Smahi C, Benaceur SM, Aguercif M. Management of beta-thalassemias in a developing country. Experience of a pediatric service in Oran (Algeria). Ann Pediatr. 1992;39:115–9.
- Government of Pakistan, Statistics Division, Federal Bureau of Statistics Islamabad. Pakistan Social and Living Standards Measurement Survey (2004–05).
- unicef.org. UNICEF; [Cited 2010 Apr 20]. Available from: www.unicef.org/
- Trent RJ. Diagnosis of the haemoglobinopathies. Clin Biochem Rev. 2006;27:27–38.
- Baig SM, Din MA, Hassan H, Azhar A, Baig JM, Aslam M, et al.. Prevention of beta-thalassemia in a large Pakistani family through cascade testing. Community Genet. 2008;11:68–70.
- Dormandy E, Bryan S, Gulliford MC, Roberts TE, Ades AE, Calnan M, et al.. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess. 2010;14:1–160.
- Bain BJ. Screening of antenatal patients in a multiethnic community for beta thalassaemia trait. J Clin Pathol. 1988;41:481–5.
- Proposed international guidelines on ethical issues in medical genetics and genetic services (part I). Rev Derecho Genoma Hum. 1998;(8):219–23.
- Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin. 2008;32:263–71.
- Tarazi I, Al Najjar E, Lulu N, Sirdah M. Obligatory premarital tests for beta-thalassaemia in the Gaza Strip: evaluation and recommendations. Int J Lab Hematol. 2007;29:111–8.
- Al-Suliman A. Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med. 2006;26:14–6.